Return to homepagePandemic Pact

Reducing the impact of major environmental challenges on mental health

Grant number: 101057429

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2027
  • Known Financial Commitments (USD)

    $9,678,458.16
  • Funder

    European Commission
  • Principal Investigator

    Schumann Gunter
  • Research Location

    Germany
  • Lead Research Institution

    CHARITE - UNIVERSITAETSMEDIZIN BERLIN
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The environMENTAL project will investigate how some of the greatest global environmental challenges, climate change, urbanisation, and psychosocial stress caused by the COVID-19-pandemic affect mental health over the lifespan. It will identify their underlying molecular mechanisms and develop preventions and early interventions. Leveraging cohort data of over 1.5 million European citizens and patients enriched with deep phenotyping data from large scale behavioural neuroimaging cohorts, we will identify brain mechanisms related to environmental adversity underlying symptoms of depression, anxiety, stress and substance abuse. By linking population and patient data via geo-location to spatiotemporal environmental data derived from remote sensing satellites, climate models, regional-socioeconomic data and digital health applications, our interdisciplinary team will develop a neurocognitive model of multimodal environmental signatures related to transdiagnostic symptom groups that are characterised by shared brain mechanisms. We will uncover the molecular basis underlying these mechanisms using multi-modal -omics analyses, brain organoids and virtual brain simulations, thus providing an integrated perspective for each individual across the lifespan and spectrum of functioning. The insight gained will be applied to developing risk biomarkers and stratification markers. We will then screen for pharmacological compounds targeting the molecular mechanisms discovered. We will also reduce symptom development and progression using virtual reality interventions based on the adverse environmental features - developed in close collaboration with stakeholders. Overall, this project will lead to objective biomarkers and evidence-based pharmacologic and VR-based interventions that will significantly prevent and improve outcomes of environmentally-related mental illnesses, and empower EU citizens to manage better their mental health and well-being.

24 Publications linked via Europe PMC

Where extended reality and AI may take us: Ethical issues of impersonation and AI fakes in social virtual reality.

Neural decision dynamics underlying reinforcement learning and working memory.

Developing brains and changing worlds: Macroenvironmental changes and their association with brain development.

The Sex-Dependent Relationship Between Amygdala Activation and Depressive Symptoms With Problematic Drinking.

Neural and psychosocial signatures of the comorbidity between pain and affective symptoms.

Variation in moment-to-moment brain state engagement follows a consistent trajectory during development.

Trajectories of delay discounting and smoking from adolescence to young adulthood.

Linking reinforcement learning, working memory, and choice dynamics to age and symptoms of anxiety and depression in adolescence.

Longitudinal Associations of Structural and Functional Brain Connectivity With Dimensions of Psychopathology in Adolescence.